The study provides a decisive view of the active implantable medical devices market by segmenting it into the product, application, end user and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2018 to 2024. The regional segmentation includes the current and forecasts demand North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa with its further categorized into major countries including the U.S., UK, Germany, France, China, Japan, India, Brazil, etc. This segmentation includes demand for active implantable medical devices market based on all segments in all the regions and countries.

Sarasota, FL -- (SBWire) -- 10/04/2018 --Zion Market Research has published a new report titled "Active Implantable Medical Devices Market by Product (Cardiac Pacemakers, Implantable Cardioverter Defibrillators, Nerve Stimulators, Cochlear Implants, Ventricular Assist Devices, and Implantable Cardiac Devices), by Application (Cardiovascular, Neurological, Hearing Impairment, and Others), and by End User (Hospitals, Specialty Clinics, & ASCs): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 – 2024". According to the report, global active implantable medical devices market was valued at approximately USD 16.47 billion in 2017 and is expected to generate revenue of around USD 23.33 billion by the end of 2024, growing at a CAGR of around 5.10% between 2018 and 2024.

Active implantable medical devices are an implantable medical device which relies on a source of electrical energy, other than energy directly generated by the human body, for its functioning. These are introduced into the body by medical or surgical procedures.

Request Free Sample Research Report @ https://bit.ly/2DW841U

Global Active Implantable Medical Devices Market

Active implantable medical devices market is segmented by product, application, and end-user. Based on the product, the active implantable medical devices market is further segmented into cardiac pacemakers, implantable cardioverter defibrillators (ICD), nerve stimulators, cochlear implants, and ventricular assist devices. The cardiac pacemakers segment is further sub-segmented into single chamber pacemakers, dual chambers pacemakers, and others. Transvenous ICD and subcutaneous ICD are included in the implantable cardioverter defibrillators segment. Nerve stimulators segment includes deep brain stimulators, vagus nerve stimulators, sacral nerve stimulators, gastric electrical stimulators, and spinal cord stimulators. Implantable cardioverter defibrillator (ICD) is anticipated to dominate the market owing to the rapid development of advanced devices & increase in demand for these devices along with rising in the incidence of arrhythmia & cardiovascular diseases.

Based on the application, the active implantable medical devices market is sub-segmented into cardiovascular, neurological, hearing impairment, and others. The cardiovascular segment is projected to dominate the active implantable medical devices market in the forecast period. The rapid increase in the occurrence of cardiovascular disorders is expected to fuel the growth of the cardiovascular segment.

The end-user segment of the active implantable medical devices market includes hospitals, specialty clinics, and ASCs. The hospital segment is expected to dominate the end-user segment due to the presence of a large patient pool in the hospitals.

Request Free Brochure of This Report: https://bit.ly/2RnJauV

Europe, Latin America, North America, Asia Pacific, and the Middle East & Africa are the regional segments of global market of active implantable medical devices. North America is anticipated to dominate the market in the forecast period due to the rise in the number of people suffering from arrhythmia and the early launch of technologically advanced products by companies in this region. Increase in the prevalence of neurological disorders and a rapid adoption of the advanced technology by the population are some of the factors fueling the growth of the market for active implantable medical devices in Europe. In the forecast period, Asia Pacific is expected to follow North America and Europe due increase in the occurrence of cardiovascular diseases and arrhythmia because of the changing lifestyle and adoption of western culture. Also, the increase in investments and product launches by various companies and less stringent laws regarding implantable devices is expected to fuel the growth of the active implantable medical devices market. Latin America & the Middle East & Africa is expected to show slow growth rate in the forecast period. Rising healthcare expenditure and increase in demand for technologically developed products in the treatment of diseases is expected to fuel the growth of active implantable medical devices market in these regions.

The key players in the global market for active implantable medical devices are Boston Scientific Corp., Cochlear Ltd., LivaNova Plc., Medtronic Plc, Sonova Holding AG, Abbott Laboratories, Nurotron Biotechnology Co. Ltd., William Demant Holding A/S, MED-EL, and Biotronik SE. The company focuses on developing technologies and launching it after the approval from FDA. For instance, in July 2018, Medtronic Plc received FDA approval for a less-invasive implant approach of HVAD(TM) System, a left ventricular assist device (LVAD). In January 2018, Abbott Laboratories received FDA approval for products namely magnetic resonance (MR)-conditional labeling for the Quadra Assura MP CRT-) and Fortify Assura ICD.

Request For Customization @ https://bit.ly/2yeebsv

This report segments the global active implantable medical devices market as follows:

Global Active Implantable Medical Devices Market: Product Segment Analysis

Cardiac Pacemakers
Single Chamber Pacemakers
Dual Chamber Pacemakers
Others
Implantable Cardioventer Defibrillators (ICD)
Transvenous ICD
Subcutaneous ICD
Nerve Simulators
Spinal Cord Simulators
Deep Brain Simulators
Sacral Nerve Simulators
Vagus Nerve Simulators
Gastric Electrical Simulators
Cochlear Implants
Ventricular Assist Devices

Global Active Implantable Medical Devices Market: Application Segment Analysis

Cardiovascular
Neurological
Hearing impairment
Others

Global Active Implantable Medical Devices Market: End-User Segment Analysis

Hospitals
Specialty Clinics
Ambulatory Surgical Centers

Global Active Implantable Medical Devices Market: Regional Segment Analysis

North America
The U.S.
Europe
UK
France
Germany
Asia Pacific
China
Japan
India
Latin America
Brazil
The Middle East and Africa

Browse the full "Active Implantable Medical Devices Market by Product (Cardiac Pacemakers, Implantable Cardioverter Defibrillators, Nerve Stimulators, Cochlear Implants, Ventricular Assist Devices, and Implantable Cardiac Devices), by Application (Cardiovascular, Neurological, Hearing Impairment, and Others), and by End User (Hospitals, Specialty Clinics, & ASCs): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 – 2024" report at https://www.zionmarketresearch.com/report/active-implantable-medical-devices-market